Anticancer nanocage platforms for combined immunotherapy designed to harness immune checkpoints and deliver anticancer drugs
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anticancer nanocage platforms for combined immunotherapy designed to harness immune checkpoints and deliver anticancer drugs
Authors
Keywords
PD-L1 binding peptide, Immune checkpoint, Ferritin, Immunotherapy, Combination therapy, Doxorubicin
Journal
BIOMATERIALS
Volume -, Issue -, Pages 120685
Publisher
Elsevier BV
Online
2021-01-22
DOI
10.1016/j.biomaterials.2021.120685
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phage display-identified PD-L1-binding peptides reinvigorate T-cell activity and inhibit tumor progression
- (2020) Smriti Gurung et al. BIOMATERIALS
- Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
- (2019) Xianjie Jiang et al. Molecular Cancer
- Recent advances in the clinical development of immune checkpoint blockade therapy
- (2019) Atefeh Ghahremanloo et al. CELLULAR ONCOLOGY
- Ferritin drug carrier (FDC) for tumor targeting therapy
- (2019) Jiuyang He et al. JOURNAL OF CONTROLLED RELEASE
- Nanocage-Therapeutics Prevailing Phagocytosis and Immunogenic Cell Death Awakens Immunity against Cancer
- (2018) Eun Jung Lee et al. ADVANCED MATERIALS
- M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors
- (2018) Yeon Woong Choo et al. ACS Nano
- Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy
- (2018) Yiyi Yan et al. Frontiers in Immunology
- Soluble immune checkpoints in cancer: production, function and biological significance
- (2018) Daqian Gu et al. Journal for ImmunoTherapy of Cancer
- PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer
- (2018) Neda Yaghoubi et al. BIOMEDICINE & PHARMACOTHERAPY
- First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
- (2017) Arjun V Balar et al. LANCET ONCOLOGY
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Mechanistic and pharmacologic insights on immune checkpoint inhibitors
- (2017) Randy F. Sweis et al. PHARMACOLOGICAL RESEARCH
- Structural basis of the therapeutic anti-PD-L1 antibody atezolizumab
- (2017) Fei Zhang et al. Oncotarget
- Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab
- (2017) Shuguang Tan et al. Protein & Cell
- Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy
- (2017) Chunlin Li et al. Cancer Immunology Research
- Designing Peptide Bunches on Nanocage for Bispecific or Superaffinity Targeting
- (2016) Sooji Kim et al. BIOMACROMOLECULES
- Combinatorial prospects of nano-targeted chemoimmunotherapy
- (2016) C.G. Da Silva et al. BIOMATERIALS
- Potential role of bioactive peptides in prevention and treatment of chronic diseases: a narrative review
- (2016) Arrigo F G Cicero et al. BRITISH JOURNAL OF PHARMACOLOGY
- PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
- (2016) Junzo Hamanishi et al. International Journal of Clinical Oncology
- Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study
- (2016) Scott Antonia et al. LANCET ONCOLOGY
- Double-Chambered Ferritin Platform: Dual-Function Payloads of Cytotoxic Peptides and Fluorescent Protein
- (2015) Soyoun Kim et al. BIOMACROMOLECULES
- Peptide therapeutics: current status and future directions
- (2015) Keld Fosgerau et al. DRUG DISCOVERY TODAY
- Cancer immunotherapy: harnessing the immune system to battle cancer
- (2015) Yiping Yang JOURNAL OF CLINICAL INVESTIGATION
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma
- (2015) Patcharee Ritprajak et al. ORAL ONCOLOGY
- Doxil Synergizes with Cancer Immunotherapies to Enhance Antitumor Responses in Syngeneic Mouse Models
- (2015) Jonathan Rios-Doria et al. NEOPLASIA
- High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma
- (2015) Yueh-Min Lin et al. PLoS One
- A Smart Platform for Hyperthermia Application in Cancer Treatment: Cobalt-Doped Ferrite Nanoparticles Mineralized in Human Ferritin Cages
- (2014) Elvira Fantechi et al. ACS Nano
- Tumor Vasculature Targeted Photodynamic Therapy for Enhanced Delivery of Nanoparticles
- (2014) Zipeng Zhen et al. ACS Nano
- Targeted In Vivo Imaging of Microscopic Tumors with Ferritin-based Nanoprobes Across Biological Barriers
- (2014) Changqian Cao et al. ADVANCED MATERIALS
- Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications
- (2014) Rongrong Jin et al. CURRENT OPINION IN PHARMACOLOGY
- Functionalization of protein-based nanocages for drug delivery applications
- (2014) Lise Schoonen et al. Nanoscale
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection
- (2014) M. Liang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Designed Nanocage Displaying Ligand-Specific Peptide Bunches for High Affinity and Biological Activity
- (2013) Jae Og Jeon et al. ACS Nano
- Proteinticle Engineering for Accurate 3D Diagnosis
- (2013) Jong-Hwan Lee et al. ACS Nano
- Think Modular: A Simple Apoferritin-Based Platform for the Multifaceted Detection of Pancreatic Cancer
- (2013) Mintai P. Hwang et al. ACS Nano
- Ferritin protein cage nanoparticles as versatile antigen delivery nanoplatforms for dendritic cell (DC)-based vaccine development
- (2013) Jae-A Han et al. Nanomedicine-Nanotechnology Biology and Medicine
- Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
- (2013) Masaru Kanekiyo et al. NATURE
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma
- (2010) Ryosuke Hino et al. CANCER
- Binding and uptake of H-ferritin are mediated by human transferrin receptor-1
- (2010) Li Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Self-assembling chimeric polypeptide–doxorubicin conjugate nanoparticles that abolish tumours after a single injection
- (2009) J. Andrew MacKay et al. NATURE MATERIALS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started